Related Experiment Video
Updated: Jun 15, 2025

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula
Wei-Jan Wang1, Hsuan-Ting Tang2, Shi-Chen Ou3
1Department of Biological Science and Technology, China Medical University, Taichung, Taiwan; Research Center for Cancer Biology, China Medical University, Taichung, Taiwan.
Abstract:
The ongoing COVID-19 pandemic is a persistent challenge, with continued breakthrough infections despite vaccination efforts. This has spurred interest in alternative preventive measures, including dietary and herbal interventions. Previous research has demonstrated that herbal medicines can not only inhibit cancer progression but also combat viral infections, including COVID-19 by targeting SARS-CoV-2, indicating a multifaceted potential to address both viruses and cancer. Here, we found that the Kang Guan Recipe (KGR), a novel herbal medicine formula, associates with potent inhibition activity against the SARS-CoV-2 viral infection. We demonstrate that KGR exhibits inhibitory activity against several SARS-CoV-2 variants of concern (VOCs). Mechanistically, we found that KGR can block the interaction of the viral spike and human angiotensin-converting enzyme 2 (ACE2). Furthermore, we assessed the inhibitory effect of KGR on SARS-CoV-2 viral entry in vivo, observing that serum samples from healthy human subjects having taken KGR exhibited suppressive activity against SARS-CoV-2 variants. Our investigation provides valuable insights into the potential of KGR as a novel herbal-based preventive and therapeutic strategy against COVID-19.
Insights
The novel Kang Guan Recipe (KGR) herbal formula shows strong potential to inhibit SARS-CoV-2 infection. KGR blocks viral entry by preventing spike protein and ACE2 interaction, offering a new COVID-19 preventive strategy.
Area of Science:
- Virology
- Immunology
- Herbal Medicine
Background:
- COVID-19 remains a global health challenge with ongoing breakthrough infections.
- Herbal medicines show promise in combating viral infections, including SARS-CoV-2.
- Interest is growing in alternative preventive strategies like dietary and herbal interventions.
Purpose of the Study:
- To investigate the inhibitory activity of the Kang Guan Recipe (KGR) against SARS-CoV-2.
- To explore the mechanism by which KGR affects SARS-CoV-2 infection.
- To assess the in vivo efficacy of KGR against SARS-CoV-2 variants.
Main Methods:
- In vitro testing of KGR against SARS-CoV-2 variants of concern (VOCs).
- Analysis of KGR's effect on the interaction between the SARS-CoV-2 spike protein and human ACE2.
- In vivo assessment of KGR's inhibitory effect on viral entry using serum from KGR-treated human subjects.
Main Results:
- KGR demonstrated potent inhibition against SARS-CoV-2 infection, including multiple VOCs.
- KGR was found to block the interaction between the viral spike protein and ACE2.
- Serum from KGR-treated individuals showed suppressive activity against SARS-CoV-2 variants in vivo.
Conclusions:
- The Kang Guan Recipe (KGR) exhibits significant antiviral activity against SARS-CoV-2.
- KGR's mechanism involves blocking the spike protein-ACE2 interaction, a key step in viral entry.
- KGR presents a promising herbal-based preventive and therapeutic option for COVID-19.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

